DexCom said Kevin R. Sayer will retire as chief executive officer effective Jan. 1, 2026, and will become executive chairman of the board on the same date to provide ongoing leadership and strategic guidance. The company also said Sayer will return from a temporary leave of absence effective March 2, 2026, resuming his executive chairman duties, and Mark Foletta will resume his role as lead independent director.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001093557-26-000038), on March 02, 2026, and is solely responsible for the information contained therein.
Comments